Segment Information (Tables)

3 Months Ended

Sep. 30, 2015

Segment Reporting Information [Line Items]

Revenue by Reportable Segment

The following table presents revenue for each reportable segment and Corporate:

	Three Months Ended September 30
(in millions)	2015			2014
Pharmaceutical	$	25,140		$	21,209
Medical	2,919			2,852
Total segment revenue	28,059			24,061
Corporate (1)	(4		)	9
Total revenue	$	28,055		$	24,070

(1) Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.

Segment Profit by Reportable Segment

The following table presents segment profit by reportable segment and Corporate:

	Three Months Ended September 30
(in millions)	2015			2014
Pharmaceutical	$	657		$	451
Medical	101			113
Total segment profit	758			564
Corporate	(138		)	(98		)
Total operating earnings	$	620		$	466

Assets by Reportable Segment

The following table presents total assets for each reportable segment and Corporate at:

(in millions)	September 30, 2015		June 30, 2015
Pharmaceutical	$	19,596	$	17,385
Medical	7,833		7,095
Corporate	3,793		5,662
Total assets	$	31,222	$	30,142